# Where to Get GLP-1 Medications: Your Guide to the Best Options
GLP-1 receptor agonists have become one of the most sought-after medications for weight management and blood sugar control. Demand has exploded since semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) hit mainstream awareness. But accessing these drugs requires knowing where to look. The landscape includes traditional pharmacies, telehealth platforms, compounding pharmacies, and specialized weight loss clinics, each with different costs, convenience levels, and medical oversight.
Noom GLP-1Rx represents one approach. The platform combines telehealth consultations with prescription fulfillment and ongoing coaching. Users answer health questions, connect with a licensed prescriber, and receive medications shipped directly if approved. Noom emphasizes behavioral support alongside pharmacotherapy. The model addresses a core problem: GLP-1s work best when combined with lifestyle changes, not as standalone solutions.
Traditional pharmacy chains like CVS, Walgreens, and Rite Aid stock brand-name GLP-1s if you have a prescription from your doctor and insurance coverage. Insurance approval varies dramatically. Many plans require prior authorization, restrict coverage to diabetes treatment only, or impose steep out-of-pocket costs. Cash prices for Wegovy run $1,500 to $1,600 per month without insurance. Mounjaro costs similarly. This gatekeeping creates access barriers for those without robust coverage.
Telehealth-only clinics have proliferated. Companies like Ro, Amazon Pharmacy (through their telehealth service), and others handle the entire process online. Patients submit medical history, receive a virtual consultation, and get prescriptions sent to a pharmacy of their choice or the service's own fulfillment center. This model works well for people already comfortable with digital health and those in areas with few local prescribers experienced with GLP-1s.
Compounding pharmacies offer another route. These facilities create custom formulations, sometimes at lower costs than brand versions. However, quality standards vary. The FDA does not regulate compounded GLP-1s with the same rigor as approved medications. Patients should verify the compounding pharmacy holds proper licensing and accreditation. Some insurance plans cover compounded versions when brand-name drugs are unavailable or unaffordable.
Weight loss clinics staffed by bariatric medicine specialists provide high-touch care. Physicians monitor patients through regular visits, adjust dosing, manage side effects, and coordinate with nutritionists and trainers. This approach costs more upfront but may prevent complications and optimize results.
Direct primary care practices sometimes offer GLP-1s to established patients. Costs remain high, but these settings prioritize continuity and personalized management.
Cost remains the biggest barrier. Without insurance, plan for $1,500 to $2,000 monthly for brand medications. Compounded versions range from $300 to $800 monthly but carry quality-control questions. Some telehealth platforms offer sliding scale pricing. A few manufacturers provide patient assistance programs for income-qualified individuals.
Before choosing a source, verify that prescribers conduct appropriate screening. GLP-1s carry real risks. Contraindications include personal or family history of medullary thyroid cancer and multiple endocrine neoplasia syndrome type 2. Side effects include nausea, vomiting, pancreatitis risk, and potential gallbladder issues. Legitimate providers ask detailed health questions and establish baseline labs.
Insurance coverage remains the determining factor for most people. Call your plan's pharmacy benefit manager to understand what GLP-1s are covered, what prior authorization steps exist, and whether you qualify. Compare out-of-pocket costs across options. If your plan does not cover GLP-1s and cash prices feel prohibitive, ask your primary care doctor about clinical trials. Multiple studies on GLP-1 efficacy continue enrolling participants nationwide.